Peripheral arterial disease: Clinical and cost comparisons between duplex US and contrast-enhanced MR angiography - A multicenter randomized trial

Radiology

Volumn 240, Issue 2, 2006, Pages 401-410

  De Vries, Marianne ^a,b   Ouwendijk, Rody ^c   Flobbe, Karin ^a   Nelemans, Patricia J ^a   Kessels, Alphons G ^a   Schurink, GeertWillem H ^a,b   Van Der Vliet, J Adam ^d   Heijstraten, Frans M J ^d   Cuypers, Philippe W M ^e   Duijm, Lucien E M ^e   Van Engelshoven, Jos M A ^a,b   Hunink, M G Myriam ^c   De Haan, Michiel W ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; EUROPEAN QUALITY OF LIFE 5D QUESTIONNAIRE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SHORT FORM 36; TREADMILL EXERCISE; VASCULAR QUALITY OF LIFE QUESTIONNAIRE; WALKING;

AGED; CONTRAST MEDIA; COSTS AND COST ANALYSIS; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; QUESTIONNAIRES; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 33746260409     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2402050223     Document Type: Review

References (33)

1. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998;18(2):185-192.
2. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20(2):384-392.
3. Elsman BH, Legemate DA, van der Heyden FW, de Vos H, Mali WP, Eikelboom BC. The use of color-coded duplex scanning in the selection of patients with lower extremity arterial disease for percutaneous transluminal angioplasty: a prospective study. Cardiovasc Intervent Radiol 1996;19(5):313-316.
4. Elsman BH, Legemate DA, van der Heijden FH, de Vos HJ, Mali WP, Eikelboom BC. Impact of ultrasonographic duplex scanning on therapeutic decision making in lower-limb arterial disease. Br J Surg 1995;82(5):630-633.
5. Koelemay MJ, den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJ. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography. Br J Surg 1996;83(3):404-409.
6. de Vries SO, Hunink MG, Polak JF. Summary receiver operating characteristic curves as a technique for meta-analysis of the diagnostic performance of duplex ultrasonography in peripheral arterial disease. Acad Radiol 1996;3(4):361-369.
7. Visser K, Hunink MG. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US - a meta-analysis. Radiology 2000;216(1):67-77.
8. Leiner T, Tordoir JH, Kessels AG, et al. Comparison of treatment plans for peripheral arterial disease made with multi-station contrast: medium-enhanced magnetic resonance angiography and duplex ultrasound scanning. J Vasc Surg 2003;37(6):1255-1262.
9. Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA 1995;274(11):875-880.
10. Carpenter JP, Baum RA, Holland GA, Barker CP. Peripheral vascular surgery with magnetic resonance angiography as the sole preoperative imaging modality. J Vasc Surg 1994;20(6):861-869.
11. Carpenter JP, Golden MA, Barker CP, Holland GA, Baum RA. The fate of bypass grafts to angiographically occult runoff vessels detected by magnetic resonance angiography. J Vasc Surg 1996;23(3):483-489.
12. Bosch JL, Hunink MG. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Med Decis Making 1996;16(3):217-225.
13. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient, groups. Med Care 1994;32(1):40-66.
14. Bosch JL, van der Graaf Y, Hunink MG. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. The Dutch Iliac Stent Trial Study Group. Circulation 1999;99(24):3155-3160.
15. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35(11):1095-1108.
16. Morgan MB, Crayford T, Murrin B, Fraser SC. Developing the vascular quality of life questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg 2001;33(4)679-687.
17. Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vasc Endovasc Surg 1995;10(3):356-361.
18. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch manual for costing in economic evaluations. Pharmacoeconomics 2002;20(7):443-454.
19. Hunink MG, Glasziou PP. Decision making in health and medicine: integrating evidence and values. Cambridge, England: Cambridge University Press, 2001.
20. Gold M, Panel on cost-effectiveness in health and medicine. Med Care 1996;34(suppl 12):DS197-DS199.
21. Visser K, de Vries SO, Kitslaar PJ, van Engelshoven JM, Hunink MG. Cost-effectiveness of diagnostic imaging work-up and treatment: for patients with intermittent claudication in the Netherlands. Eur J Vasc Endovasc Surg 2003;25(3):213-223.
22. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276(16):1339-1341.
23. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Clin Oral Investig 2003;7(1):2-7.
24. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). Trans-Atlantic Inter-Society Consensus (TASC) Working Group. J Vasc Surg 2000;31 (suppl 1):S1-S296.
25. Koelemay MJ, Legemate DA, van Gurp J, Ponson AE, Reekers JA, Jacobs MJ, Colour duplex scanning and pulse-generated run-off for assessment of popliteal and cruropedal arteries before peripheral bypass surgery. Br J Surg 1997;84(8):1115-1119.
26. Koelemay MJ, Legemate DA, de Vos H, et al. Duplex scanning allows selective use of arteriography in the management of patients with severe lower leg arterial disease. J Vasc Surg 2001;34(4):661-667.
27. Grassbaugh JA, Nelson PR, Rzucidlo EM, et al. Blinded comparison of preoperative duplex ultrasound scanning and contrast arteriography for planning revascularization at the level of the tibia. J Vasc Surg 2003;37(6):1186-1190.
28. Swan JS, Kennell TW, Acher CW, et al. Magnetic resonance angiography of aorto-iliac disease. Am J Surg 2000;180(1):6-12.
29. Eiberg JP, Lundorf E, Thomsen C, Schroeder TV. Peripheral vascular surgery and magnetic resonance arteriography: a review. Eur J Vasc Endovasc Surg 2001;22(5):396-402.
30. Jansen RM, de Vries SO, Cullen KA, Donaldson MC, Hunink MG. Cost-identification analysis of revascularization procedures on patients with peripheral arterial occlusive disease. J Vasc Surg 1998;28(4):617-623.
31. Bosch JL, Haaring C, Meyerovitz MF, Cullen KA, Hunink MG. Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States. AJR Am J Roentgenol 2000;175(2):517-521.
32. Bosch JL, Tetteroo E, Mali WP, Hunink MG. Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Dutch Iliac Stent Trial Study Group. Radiology 1998;208(3):641-648.
33. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995;14(2):171-189.